NCT00102609 2013-01-10A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue SarcomaJohnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 1 Completed41 enrolled